Acumen Pharmaceuticals Inc (ABOS)
2.31
-0.06
(-2.53%)
USD |
NASDAQ |
Nov 21, 16:00
2.305
0.00 (0.00%)
Pre-Market: 20:00
Acumen Pharmaceuticals Total Liabilities (Quarterly): 49.77M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 49.77M |
| June 30, 2024 | 44.97M |
| March 31, 2024 | 38.93M |
| December 31, 2023 | 43.15M |
| September 30, 2023 | 6.098M |
| June 30, 2023 | 8.531M |
| March 31, 2023 | 8.779M |
| December 31, 2022 | 7.812M |
| Date | Value |
|---|---|
| September 30, 2022 | 6.613M |
| June 30, 2022 | 5.159M |
| March 31, 2022 | 3.998M |
| December 31, 2021 | 5.147M |
| September 30, 2021 | 1.489M |
| June 30, 2021 | 179.02M |
| March 31, 2021 | 87.84M |
| December 31, 2020 | 63.02M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.489M
Minimum
Sep 2021
179.02M
Maximum
Jun 2021
35.02M
Average
8.655M
Median
Total Liabilities (Quarterly) Benchmarks
| Kodiak Sciences Inc | 187.30M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 266.98M |
| Shareholders Equity (Quarterly) | 217.20M |